Sterling Accuris Diagnostics, one of the fastest growing chains of NABL accredited pathology laboratory in India with a leading presence in Gujarat, Rajasthan, and Madhya Pradesh, has announced the acquisition of Gujarat & Maha Gujarat Pathology Laboratories, a leading pathology service provider in Ahmedabad.
This acquisition is poised to significantly increase the footprints of Sterling Accuris across the length and breadth of Ahmedabad and add value to service excellence across the diagnostics landscape.
Sterling Accuris is a strong, customer-centric brand known for providing ethical and market-appropriate pathology diagnostic services. It offers reliable, accurate, and dependable solutions to individual patients, hospitals, and corporates.
While Gujarat Pathology Laboratory has been serving Ahmedabad since 1998 and offering a comprehensive range of diagnostic services from Hematology, Biochemistry, and Immunology to Molecular Biology. With a network of 8 laboratories and more than 20 collection centres across Ahmedabad, it has served nearly 20 lakh patients so far.
Rajiv Sharma, Managing Director of Sterling Accuris said, “Gujarat Pathology Laboratory has been serving Ahmedabad for the past 27 years, with a strong presence and reputation in the market. Our acquisition of Gujarat Pathology Laboratory will enable us to serve a larger patient base in Ahmedabad by leveraging their strengths in the B2C segment. This collaboration will not only strengthen our service network but also enhance the reach and quality of diagnostic services we offer across Ahmedabad & Gujarat.”
Dr Niraj Kothari, Founder, and Vishnubhai Patel, Co-Founder of Gujarat Pathology Laboratory, along with Navinbhai Patel, Founder of Maha Gujarat Pathology Laboratory, stated, "Sterling Accuris brings a strong and established presence in the diagnostics market, and we see this partnership as a valuable opportunity to scale our services. Gujarat Pathology has a solid foundation in Ahmedabad, and with this acquisition, we will be able to leverage the high-end technology available with Sterling Accuris. This collaboration will enable us to offer a wide range of diagnostic tests, helping us expand our reach and improve accessibility."
